Abstract
Recently, a few animals have been frequently reported to have been diagnosed with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Whether they are SARS-CoV-2 intermediate hosts is worthy of great attention. The interaction of SARS-CoV-2 spike protein and its acceptor protein ACE2 is an important issue in determining viral host range and cross-species infection, while the binding capacity of Spike protein to ACE2 of different species is unknown. Here, we used the atomic structure model of SARS-CoV-2 and human ACE2 to assess the receptor utilization capacity of ACE2s from 10 kinds of animals. Results show that chimpanzees, domestic cats and cattles are more susceptible to infection by SARS-CoV-2. Cats in particular, such as pet cats and stray cats, interact very closely with humans, implying the necessity to carefully evaluate the risk of cats during the current COVID-19 pandemic. Furthermore, based on ACE2(cats)-SARS-CoV-2-RBD model, through high-throughput screening methods using a pool of 30,000 small molecules, eight compounds were selected for binding free energy calculations. All the eight compounds can effectively interfere with the binding of ACE2 and Spike protein, especially Nelfinavir, providing drug cand...Continue Reading
References
May 1, 1995·Journal of Cardiovascular Pharmacology·M MetraL D Cas
Sep 13, 2000·Drugs·D P Figgitt, G L Plosker
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Arthur A HancockMichael Williams
Jan 24, 2002·The Journal of Pharmacology and Experimental Therapeutics·Michael E BruneMichael Williams
Oct 31, 2003·Nature·Byron E E MartinaAlbert D M E Osterhaus
May 18, 2004·Biochemical and Biophysical Research Communications·Norio YamamotoNaoki Yamamoto
Jul 7, 2010·Antiviral Research·Li-En HsiehLing-Ling Chueh
Oct 19, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Stefan ZeuzemGraham R Foster
Feb 9, 2012·Advances in Virology·Sophie Le Poder
Feb 7, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·David L WylesMark S Sulkowski
Feb 28, 2014·Journal of Virology·Nene N KaluRichard F Ambinder
Jul 1, 2014·European Journal of Pharmacology·Ma Trinidad Villamil-HernándezDavid Centurión
Dec 3, 2014·Clinical Therapeutics·Navita L MallalieuJames L Freddo
Feb 25, 2015·Advances in Virology·Soren GanttMichael Lagunoff
Apr 4, 2015·Expert Opinion on Drug Discovery·Samuel Genheden, Ulf Ryde
Oct 19, 2019·Headache·Mark ConnellyJennifer Bickel
Jan 25, 2020·The New England Journal of Medicine·Na ZhuUNKNOWN China Novel Coronavirus Investigating and Research Team
Jan 31, 2020·Journal of Virology·Yushun WanFang Li
Feb 3, 2020·Lancet·Roujian LuWenjie Tan
Feb 6, 2020·Science China. Life Sciences·Xintian XuPei Hao
Aug 1, 2006·Biological Conservation·Stephen J O'BrienJill Pecon-Slattery
Apr 10, 2020·Science·Jianzhong ShiZhigao Bu
Apr 14, 2020·Computational and Structural Biotechnology Journal·Bo Ram BeckKeunsoo Kang
Citations
Jun 10, 2021·Molecular Diversity·Juan WangXuyan Fu
Aug 3, 2021·Frontiers in Immunology·Zhihui WangLing Zhao
Aug 8, 2021·Animals : an Open Access Journal From MDPI·Kimberly EkstrandKathleen N Morgan